Cargando…
Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplastic disorder, characterized by recurrent nosebleeds (epistaxis), multiple telangiectases and arteriovenous malformations (AVMs) in major organs. Mutations in Endoglin (ENG or CD105) and Activin receptor-like kinase...
Autores principales: | Ardelean, Daniela S., Letarte, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324154/ https://www.ncbi.nlm.nih.gov/pubmed/25717337 http://dx.doi.org/10.3389/fgene.2015.00035 |
Ejemplares similares
-
Contribution of oxidative stress to endothelial dysfunction in hereditary hemorrhagic telangiectasia
por: Jerkic, Mirjana, et al.
Publicado: (2015) -
Potential Second-Hits in Hereditary Hemorrhagic Telangiectasia
por: Bernabeu, Carmelo, et al.
Publicado: (2020) -
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
por: Shovlin, Claire L.
Publicado: (2015) -
Oxidative Stress Contributes to Endothelial Dysfunction in Mouse Models of Hereditary Hemorrhagic Telangiectasia
por: Jerkic, Mirjana, et al.
Publicado: (2012) -
Circulating Angiogenic Cell Dysfunction in Patients with Hereditary Hemorrhagic Telangiectasia
por: Zucco, Liana, et al.
Publicado: (2014)